View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 24, 2019updated 12 Jul 2022 12:28pm

ClinOne to offer free patient recruitment to sponsors in 2020

ClinOne, a provider of technologies for clinical trials, is set to launch a direct-to-patient recruitment platform in the first quarter of next year.

ClinOne , a provider of technologies for clinical trials, is set to launch a direct-to-patient recruitment platform in the first quarter of next year.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

The new platform, known as ClinTrialConnect, will provide recruitment in the first quarter of the year in the US, expanding to other regions the subsequent quarter. It will enable patients to navigate clinical trial options from their home or place of work.

The new technology will automatically integrate with disease associations and social media, including Google and Facebook.

ClinTrialConnect technology will include screening questions for patients, thereby, mitigating unqualified patients being admitted into trials.

According to the company, the series of screening questions for patients and their caretakers will be designed to better understand their disease and identify which patients match a specific trial.

ClinOne CEO Rob Bohacs said: “In our initial launch phase of this technology, we would like to have sponsors pilot our technology at no cost through 2020, measure success, and provide valuable feedback to our organization.

“This feedback will ultimately benefit all sponsors as it will help us improve upon the app, should we see from the data that this is indicated.”

In May this year, ClinOne unveiled the new Bring Your Own Device (BYOD) electronic patient-reported outcome (ePRO) to ensure zero data loss at clinical trial sites.

The solution is anticipated to support site sponsors by reducing the cost over hardware-derived ePRO solutions and the need to allocate provisioned devices.

Based in Denver, Colorado, ClinOne is a provider of mobile and web applications that enhance patient, family, and site engagement.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena